Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: CXCR2
Name: C-X-C motif chemokine receptor 2
Location: 02q35
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT02469298 Safety Tolerability and Clinical Effect of Danirixin in Adults With Influenza View
NCT02927431 Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza View
NCT03177187 Combination Study of AZD5069 and Enzalutamide View
NCT00504439 A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects View
NCT01453478 A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced View
NCT02201303 Evaluation of Danirixin GSK1325756 Inhibition of CD11b Cell Surface Expression View
NCT01209052 First Time in Human Study With GSK1325756 View
NCT01740557 Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma View
NCT03034967 Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease COPD View
NCT04105959 A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model View
NCT02130193 Investigation of Safety Tolerability Pharmacokinetics Pharmacodynamics and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations View
NCT00851955 Role of CXCR2 LigandsCXCR2 Biological Axis in Pancreatic Cancer View
NCT01006616 Long-Term Study of the Effects of Navarixin SCH 527123 MK-7123 in Participants With Moderate to Severe COPD MK-7123-019 View
NCT01209104 Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors View
NCT03136380 Study of Danirixin in Japanese Healthy Elderly Male Subjects View
NCT03250689 Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps NETs in Chronic Obstructive Pulmonary Disease COPD View